János Filakovský

Life Sciences and Biopharmaceutical sector Executive, CEO, NED, Board Coach, Business Partner, Independent Consultant

Austria

About

Life Sciences and Biopharmaceutical sector CEO and Non-Executive Director with extensive professional experience in leading strategically and operationally complex, large-scale, highly regulated international multi-site operations, delivering transformation, and driving sustainable performance improvements. Leadership at public, PE/VC, and family-owned large and mid-sized organizations is underpinned by corporate governance expertise gained within IQVIA (Quintiles) Holdings, TFS International AB, and Biomapas. Consultant and Adviser in Life Sciences to PE/VC firms and Governmental Organizations, affiliated as a part-time Associate Professor with the Institute of Digital Health Sciences. Personal qualities of integrity, credibility, and passion for improving lives and health care. An independent thinker, who is comfortable with challenges, in an appropriate manner. Diplomatic skills and natural affinity for cultivating relationships convening, facilitating, and building consensus among diverse teams.

Experience

  • Partner, Chief Business Officer at Allyfe
    Jan 2026 - Present · 7 mos

  • Independent Life Sciences Consultant, Advisor at Jan Filakovsky Consulting
    Feb 2021 - Present · 5 yrs 6 mos

  • Semmelweis University (9 yrs)
    • Associate Professor at Semmelweis University Institute of Digital Health Sciences
      Aug 2017 - Present · 9 yrs

    • Director at Semmelweis University Clinical Research Coordinating Center
      May 2021 - May 2022 · 1 yr 1 mo

  • Biomapas (3 yrs 11 mos)
    • Business Consultant
      Jan 2025 - Dec 2025 · 1 yr

    • Chief Executive Officer
      Mar 2023 - Dec 2024 · 1 yr 10 mos

    • Non Executive Director
      Feb 2022 - Mar 2023 · 1 yr 2 mos

      Non-Executive Director, Board member

  • TFS - Clinical Contract Research Organization ()
    • Biopharmaceutical Services Executive
      Feb 2018 - Jun 2020 · 2 yrs 5 mos

    • Chief Executive Officer
      Feb 2018 - Dec 2019 · 1 yr 11 mos